GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ATAI Life Sciences NV (FRA:9VC) » Definitions » Price-to-Funds-From-Operations

ATAI Life Sciences NV (FRA:9VC) Price-to-Funds-From-Operations : (As of Mar. 27, 2025)


View and export this data going back to 2021. Start your Free Trial

What is ATAI Life Sciences NV Price-to-Funds-From-Operations?

Price-to-Funds-From-Operations only applies to REITs.


ATAI Life Sciences NV Business Description

Traded in Other Exchanges
Address
Wallstrasse 16, Berlin, BB, DEU, 10179
ATAI Life Sciences NV is a clinical-stage biopharmaceutical company on a mission to develop effective mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 (buccal film DMT) for treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder. It is also advancing a drug discovery program to identify novel, non-hallucinogenic 5-HT2AR agonists for TRD.